PMID- 32279539
OWN - NLM
STAT- MEDLINE
DCOM- 20210607
LR  - 20211002
IS  - 1524-4539 (Electronic)
IS  - 0009-7322 (Linking)
VI  - 141
IP  - 19
DP  - 2020 May 12
TI  - Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 
      Diabetes Mellitus: A Scientific Statement From the American Heart Association.
PG  - e779-e806
LID - 10.1161/CIR.0000000000000766 [doi]
AB  - Although cardiologists have long treated patients with coronary artery disease 
      (CAD) and concomitant type 2 diabetes mellitus (T2DM), T2DM has traditionally 
      been considered just a comorbidity that affected the development and progression 
      of the disease. Over the past decade, a number of factors have shifted that have 
      forced the cardiology community to reconsider the role of T2DM in CAD. First, in 
      addition to being associated with increased cardiovascular risk, T2DM has the 
      potential to affect a number of treatment choices for CAD. In this document, we 
      discuss the role that T2DM has in the selection of testing for CAD, in medical 
      management (both secondary prevention strategies and treatment of stable angina), 
      and in the selection of revascularization strategy. Second, although glycemic 
      control has been recommended as a part of comprehensive risk factor management in 
      patients with CAD, there is mounting evidence that the mechanism by which glucose 
      is managed can have a substantial impact on cardiovascular outcomes. In this 
      document, we discuss the role of glycemic management (both in intensity of 
      control and choice of medications) in cardiovascular outcomes. It is becoming 
      clear that the cardiologist needs both to consider T2DM in cardiovascular 
      treatment decisions and potentially to help guide the selection of 
      glucose-lowering medications. Our statement provides a comprehensive summary of 
      effective, patient-centered management of CAD in patients with T2DM, with 
      emphasis on the emerging evidence. Given the increasing prevalence of T2DM and 
      the accumulating evidence of the need to consider T2DM in treatment decisions, 
      this knowledge will become ever more important to optimize our patients' 
      cardiovascular outcomes.
FAU - Arnold, Suzanne V
AU  - Arnold SV
FAU - Bhatt, Deepak L
AU  - Bhatt DL
FAU - Barsness, Gregory W
AU  - Barsness GW
FAU - Beatty, Alexis L
AU  - Beatty AL
FAU - Deedwania, Prakash C
AU  - Deedwania PC
FAU - Inzucchi, Silvio E
AU  - Inzucchi SE
FAU - Kosiborod, Mikhail
AU  - Kosiborod M
FAU - Leiter, Lawrence A
AU  - Leiter LA
FAU - Lipska, Kasia J
AU  - Lipska KJ
FAU - Newman, Jonathan D
AU  - Newman JD
FAU - Welty, Francine K
AU  - Welty FK
CN  - American Heart Association Council on Lifestyle and Cardiometabolic Health and 
      Council on Clinical Cardiology
LA  - eng
GR  - K23 HL125991/HL/NHLBI NIH HHS/United States
PT  - Journal Article
PT  - Practice Guideline
PT  - Review
DEP - 20200413
PL  - United States
TA  - Circulation
JT  - Circulation
JID - 0147763
RN  - 0 (Hypoglycemic Agents)
SB  - IM
MH  - American Heart Association
MH  - Clinical Decision-Making
MH  - Comorbidity
MH  - Consensus
MH  - Coronary Artery Disease/diagnosis/epidemiology/*therapy
MH  - Diabetes Mellitus, Type 2/diagnosis/epidemiology/*therapy
MH  - Humans
MH  - Hypoglycemic Agents/*therapeutic use
MH  - Myocardial Revascularization/*standards
MH  - Patient-Centered Care/*standards
MH  - Risk Assessment
MH  - Risk Factors
MH  - *Risk Reduction Behavior
MH  - Secondary Prevention/*standards
MH  - Treatment Outcome
MH  - United States
OTO - NOTNLM
OT  - AHA Scientific Statements
OT  - blood glucose
OT  - coronary artery disease
OT  - diabetes mellitus, type 2
OT  - patient-centered care
OT  - secondary prevention
EDAT- 2020/04/14 06:00
MHDA- 2021/06/08 06:00
CRDT- 2020/04/14 06:00
PHST- 2020/04/14 06:00 [pubmed]
PHST- 2021/06/08 06:00 [medline]
PHST- 2020/04/14 06:00 [entrez]
AID - 10.1161/CIR.0000000000000766 [doi]
PST - ppublish
SO  - Circulation. 2020 May 12;141(19):e779-e806. doi: 10.1161/CIR.0000000000000766. 
      Epub 2020 Apr 13.